Does the COMT rs4680 AA genotype increase nighttime arousal vulnerability?

The catechol-O-methyltransferase (COMT) gene rs4680 polymorphism plays a critical role in regulating neurotransmitter clearance, directly influencing sleep architecture and stress-induced hyperarousal.

Enzymatic impact of the COMT AA genotype

• Reduced catalytic activity: The COMT rs4680 AA (Met/Met) genotype produces a thermolabile variant of the enzyme, resulting in a 3- to 4-fold reduction in catalytic activity compared to the GG (Val/Val) genotype.
• Compromised clearance: This variant causes a 55% to 75% reduction in overall functional clearance capacity, representing the classic "slow COMT" phenotype.

Mechanisms of persistent signaling

• Prolonged synaptic presence: Slower enzymatic breakdown delays the degradation of norepinephrine, epinephrine, and dopamine.
• Elevated baseline levels: Rather than undergoing rapid metabolism, these catecholamines persist in the synaptic cleft and extracellular spaces, driving sustained adrenergic signaling and elevated baseline dopamine levels in the prefrontal cortex.

Vulnerability to nighttime arousal

• Disrupted sleep microarchitecture: Central norepinephrine signaling from the locus coeruleus (LC) is a primary wake-promoting pathway. Elevated or persistent noradrenergic tone during non-REM sleep triggers autonomic-subcortical and cortical microarousals.
• Sleep fragmentation: This sustained hyperarousal suppresses stable, spindle-rich sleep segments and increases susceptibility to sensory-evoked awakenings, leading to prolonged sleep latency and increased wake after sleep onset (WASO).

Bottom line

• The COMT rs4680 AA genotype represents a low-activity state that reduces catecholamine clearance 3- to 4-fold, prolonging noradrenergic signaling to directly increase cortical microarousals and nighttime sleep fragmentation.